CYC116 is a potent, selective dual Aurora A/B kinase inhibitor (Ki = 8.0/9.2 nM) with weaker activity against VEGFR2 and minimal off-target effects on other key kinases. It has been utilized in preclinical research to investigate cell cycle disruption and antitumor efficacy in both cellular and animal models.
Molecular Weight:
368.46
Purity:
97.59% (May vary between batches)
CAS Number:
[693228-63-6]
Formula:
C18H20N6OS
Target:
S6 Kinase,CDK,Aurora Kinase,FLT,VEGFR
Application Notes:
Solubility: H2O:< 1 mg/mL (insoluble or slightly soluble),DMSO:13.4 mg/mL (36.37 mM),Ethanol:< 1 mg/mL (insoluble or slightly soluble)
* VAT and and shipping costs not included. Errors and price changes excepted